SanBio Updates on Development of SB623 Drug for Chronic Effects of Traumatic Brain Injury
SanBio Updates on Development of SB623 Drug for Chronic Effects of Traumatic Brain Injury
SanBio关于SB623药物治疗创伤性脑损伤慢性效应的最新进展
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册